fashion -WSS

fashion

author：entertainment 2025-10-01 18:33:49 - browse：79

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Food as medicine: Medically tailored meals may get standardized

entertainment

hotspot

WSS

There's no autism epidemic. It's an autism diagnosis epidemic

Primary care physicians play key roles in Alzheimer's management

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Eye stem cell transplant could help restore vision in injured people

Cancer drug shortages' outsize impact on ovarian cancer patients

hotspot

fashion

Wikipedia

New air purifier tech could be key to improving indoor air quality

Supreme Court mifepristone arguments center on docs' right to sue

Tori Bowie and the unacceptable rates of Black maternal death

States should stop sabotaging methadone treatment reform

George Santos makes 1st court appearance after pleading not guilty to 13 counts

An interview with Robert F. Kennedy Jr. on vaccines

Duchenne breakthrough therapy leaves behind pioneering families

Liz Cheney makes 1st public comment since Trump's election interference indictments

Wildfire smoke exposes gaps in outdoor worker protections

Washington mulls new rules to avert another Change Healthcare

focus

There's no autism epidemic. It's an autism diagnosis epidemic

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Primary care physicians play key roles in Alzheimer's management

Patient advocates sound warning on FDA proposal on salt intake

Patient advocates sound warning on FDA proposal on salt intake

Baltimore teen accused of firing into crowd during block party mass shooting

hotspot

entertainment

hotspot

knowledge